Pharmabiz57m
US FDA grants breakthrough therapy designation to Johnson & Johnson’s nipocalimab to treat adults living with moderate-to-severe Sjögren's disease
Johnson & Johnson announced that the US Food and Drug Administration (FDA) has granted nipocalimab Breakthrough Therapy designation (BTD) for the treatment of adults living with moderate-to-severe ...
Pharmabiz1h
Merck to present new data from Gardasil 9 studies reinforcing the importance of gender-neutral HPV vaccination in adults up to age 45 at IPVC 2024
Rahway, New Jersey Wednesday, November 13, 2024, 13:00 Hrs [IST] ...
Pharmabiz2h
Vitonnix UK joins SEARCH Foundation in its mission to target the vitamin D deficiency endemic in rural India
The SEARCH Foundation, known for its transformative healthcare efforts in rural India, has announced a significant ...
Pharmabiz2h
AstraZeneca, Daiichi Sankyo seek US FDA’s accelerated approval for datopotamab deruxtecan to treat advanced EGFR-mutated NSCLC
AstraZeneca, Daiichi Sankyo seek US FDA’s accelerated approval for datopotamab deruxtecan to treat advanced EGFR-mutated NSCLC ...
Pharmabiz3h
Arch Biopartners doses first patient in Canada for phase II trial of LSALT peptide to treat cardiac surgery associated acute kidney injury
Arch Biopartners doses first patient in Canada for phase II trial of LSALT peptide to treat cardiac surgery associated acute kidney injury: Toronto Wednesday, November 13, 2024, 1 ...
Pharmabiz4h
Transforming future eye care with AI in ophthalmology
Ophthalmology has emerged as a subject where artificial intelligence (AI) holds great promise. Major developments in artificial intelligence technology over the last five years have created new ...
Pharmabiz4h
Boehringer Ingelheim and MTM Vision join forces to combat vision loss from diabetes
Boehringer Ingelheim and the Mary Tyler Moore Vision Initiative (MTM Vision) jointly announce the start of a long-term collaboration as Boehringer becomes the first pharmaceutical company to join the ...
Pharmabiz5h
AstraZeneca to invest $3.5 billion in R&D and manufacturing in US
AstraZeneca to invest $3.5 billion in R&D and manufacturing in US: Cambridge, UK Wednesday, November 13, 2024, 09:00 Hrs [IST] AstraZeneca, a global, science-led biopharmaceutical ...
Pharmabiz6h
Inter-ministerial committee calls for amendment in FSSAI Act on nutraceuticals
Inter-ministerial committee calls for amendment in FSSAI Act on nutraceuticals: Gireesh Babu, New Delhi Wednesday, November 13, 2024, 08:00 Hrs [IST] An inter-ministerial committe ...
Pharmabiz6h
NABL announces joint technical training programme with MANTRA on medical textiles testing
NABL announces joint technical training programme with MANTRA on medical textiles testing: Shardul Nautiyal, Mumbai Wednesday, November 13, 2024, 08:00 Hrs [IST] The National Accr ...
Pharmabiz6h
Indian pharma stresses for enhanced fire safety measures and improved insurance coverage for employees
Indian pharma stresses for enhanced fire safety measures and improved insurance coverage for employees: Nandita Vijayasimha, Bengaluru Wednesday, November 13, 2024, 08:00 Hrs [IST ...
Pharmabiz6h
Industry hails DoP's new scheme for strengthening of medical devices industry
Industry hails DoP's new scheme for strengthening of medical devices industry: Our Bureau, New Delhi Wednesday, November 13, 2024, 08:00 Hrs [IST] The centrally sponsored scheme f ...